Prostate Artery Embolization: Long-Term Outcomes and Selection for High-Risk Surgical Patients

Prostate artery embolization has emerged as a minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. While transurethral resection of the prostate remains the reference standard, this procedure offers a compelling alternative for patients who are poor surgical candidates or who prioritize preservation of sexual function. This mini-review synthesizes the current evidence on long-term durability and delineates patient selection criteria, with particular emphasis on non-surgical candidates. Data from large cohort studies randomized controlled trials, systematic reviews, and multisociety consensus statements are reviewed. The technique demonstrates sustained symptomatic improvement with acceptable reintervention rates and a favorable safety profile. It offers unique advantages in